Five Prime Therapeutics, Inc. News Headlines

Get FPRX Alerts
*Delayed - data as of Dec. 17, 2014  -  Find a broker to begin trading FPRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    FPRX Pre-Market
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By
Five Prime To Present At Oppenheimer Conference; Webcast At 3:55 PM ET
12/10/2014 2:55:00 PM - RTT News

CLRB Spikes Over 13%, OVAS In Good Health, INCY, MYL Get FDA Nod
12/5/2014 12:20:00 AM - RTT News

Five Prime Therapeutics To Participate In Piper Jaffray Conference At 12:30PM ET
12/3/2014 11:30:00 AM - RTT News

Five Prime Therapeutics Up on Deal with Bristol-Myers - Analyst Blog
11/26/2014 4:30:00 PM - Zacks.com

Five Prime Therapeutics, Inc. (FPRX) in Focus: Stock Soars 31.4% - Tale of the Tape
11/25/2014 9:18:00 AM - Zacks.com

FPRX Gets High Five, CLRX Put On Notice, RNA Snapped Up, Natesto Changes Hands
11/25/2014 12:07:00 AM - RTT News

Monday Sector Leaders: Music & Electronics Stores, Drugs
11/24/2014 1:57:14 PM - BNK Invest

Five Prime Therapeutics (FPRX) Is Up Sharply After BMY Collaboration
11/24/2014 10:03:00 AM - RTT News

Bristol-Myers, Five Prime to Collaborate on Immunotherapy
11/24/2014 9:40:00 AM - Dow Jones Business News

Bristol-Myers, Five Prime Therapeutics Enter Into Clinical Collaboration Deal
11/24/2014 9:20:00 AM - RTT News

Five Prime Therapeutics Expands Collaboration With GSK
10/24/2014 1:03:00 AM - RTT News

Five Prime Therapeutics' Novel Target Licensed by Glaxo - Analyst Blog
9/17/2014 5:00:00 PM - Zacks.com

Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies
8/12/2014 10:43:00 AM - Seeking Alpha

Five Prime Therapeutics (FPRX) Jumps: Stock Adds 10.3% in Session - Tale of the Tape
8/12/2014 7:51:00 AM - Zacks.com

Bristol-Myers & CytomX Therapeutics Join Forces - Analyst Blog
5/28/2014 10:50:00 AM - Zacks.com

Bristol-Myers, Samsung BioLogics Extend Ties - Analyst Blog
4/23/2014 4:30:01 PM - Zacks.com

Should Five Prime Therapeutics (FPRX) Be On Your Radar Now? - Tale of the Tape
4/10/2014 7:53:01 AM - Zacks.com

Earnings Estimates Moving Higher for Five Prime (FPRX): Time to Buy? - Tale of the Tape
4/4/2014 7:47:01 AM - Zacks.com

Bristol Myers Deal Overshadows Q4 loss at Five Prime - Analyst Blog
3/27/2014 10:00:01 AM - Zacks.com

Bristol-Myers, Five Prime Join Forces, Shares up - Analyst Blog
3/18/2014 11:00:01 AM - Zacks.com

Five Prime Therapeutics (FPRX) Surges: Stock Moves 22.6% Higher - Tale of the Tape
3/18/2014 8:18:01 AM - Zacks.com

Five Prime: A Growing Oncology And Inflammatory Player With A Promising Pipeline
10/30/2013 2:47:00 PM - Seeking Alpha

Five Prime Therapeutics - Another Risky Cancer Research Public Offering
9/23/2013 7:05:00 AM - Seeking Alpha

Five Prime Therapeutics prices IPO at $13, within the range
9/17/2013 7:08:06 PM - Renaissance Capital

IPO Preview: Five Prime Therapeutics
9/17/2013 4:34:00 PM - Seeking Alpha